Trial · NCT06754579
Impact of High-Volume Upper Limb Training on Physical and Cognitive Outcomes
NCT06754579, Not applicable, Recruiting, Tarsus University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Impact of High-Volume Upper Limb Training on Physical and Cognitive Outcomes. Trials, record NCT06754579. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06754579
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Impact of High-Volume Upper Limb Training on Physical and Cognitive Outcomes
- NCT number
- NCT06754579
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 32 participants, estimated
- Lead sponsor
- Tarsus University
- Conditions
- Sedentary Behavior
- Interventions
- High-Volume Upper Extremity Exercises Training, Low Volume Upper Extremity Exercises Training
- First posted
- 2025-01-01
- Last updated
- 2026-01-21
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | International Physical Activity Questionnaire-Short Form (IFQQ-SF) | eight weeks | International Physical Activity Questionnaire-Short Form (IFQQ-SF): UFQ-SF was developed by Craig and colleagues to determine the physical activity levels of individuals between the ages of 15-65. The short form is recommended more because the long form is boring and repetitive, so the "last 7 days" short form was used in our study. The short form (7 questions) provides information on time spent in sitting, walking, moderate-intensity and vigorous activities. The total score is expressed as one MET-min/week and is obtained by multiplying the number of days and minutes of walking, moderate-intensity and vigorous activity and the MET score. |
| Secondary | Maximal Arm Exercise Capacity | Eight weeks | The arm ergometer test is a widely used method to evaluate maximal arm exercise capacity, requiring the involvement of chest, back, hip, and leg muscles for body stabilization. This is particularly important as the test primarily targets a smaller muscle mass compared to bicycle ergometer testing. For this study, the Monark 881E Rehab Trainer (MONARK 881E, Monark, Varberg, Sweden) arm ergometer will be employed. |
| Secondary | Stroop Test | Eight weeks | The Stroop Test utilized in this study is based on the Istanbul Medical Faculty (Çapa) Neuropsychology Laboratory adaptation of the Stroop Test form originally developed by Weintraub (2000). Participants are instructed to name the colors of the small rectangles (red, blue, green) as quickly as possible, moving from left to right. This stage is used to identify any visual or color perception impairments, such as color blindness. If such deficiencies are detected, the test is discontinued.Stroop B (word reading): Participants are asked to read aloud the printed color names (red, blue, green) that are written in incompatible ink colors as quickly as possible. Stroop C (Color-Word Interference). |
| Secondary | Reaction Time | Eight weeks | The auditory and visual reaction times of sedentary individuals will be assessed using the Newtest 1000™ device (OY, Oulu, Finland). This device is capable of delivering three types of stimuli and consists of two primary components designed for precise reaction time measurements.Following the familiarization trial, three measurements will be conducted for each type of stimulus (auditory and visual), and the reaction times will be recorded in milliseconds. This protocol ensures the reliability of the data and accounts for variability in individual performance. |
| Secondary | Hole Type Steadiness Tester | Eight weeks | The participant will be asked to hold a metal tipped pencil with his dominant hand for 15 seconds in the 9 holes that are gradually decreasing in size without touching the edges. The purpose of the test will be to analyze the stability of the hand, exercise, smoking, alcohol intake, psychomotor speed, exercise and fatigue. Errors that occur when the participant touches the hole area will be recorded digitally. The test will be repeated 3 times on average and the result value will be calculated. |
| Secondary | Postural Sway Assessment | Eight weeks | Postural sway was assessed using the GYKO body sway device (Microgait, Italy), a validated tool that measures sway along two axes: mediolateral and anteroposterior (Jaworski et al., 2020). During the assessment, participants were instructed to stand in an upright posture with their feet positioned 10 cm apart and to maintain this posture for a duration of 30 seconds. Each participant underwent two trials under different visual conditions: eyes open and eyes closed. The mediolateral and anteroposterior sway distances were recorded for each trial. Data were automatically captured and stored in the accompanying computer software for subsequent analysis. This protocol ensures a reliable evaluation of postural control and stability under varying sensory conditions. |
| Secondary | Upper Extremity Muscle Strength Assessment | Eight weeks | MicroFET 2 muscle strength is a usable method for measuring muscle strength (Malliopoulos \& Thevenon, 2002). Muscle strength is defined as the highest (maximal) voluntary contraction that the subject can perform under specific test conditions. The individual performed the highest voluntary contraction 3 times for each test. The individual increases his strength for 2 seconds and maintains it at the highest level for 3 seconds. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as |
|---|---|
| Stroop Color-Word Test | Secondary outcome |
Source ConductCognition
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06754579
GET https://conductscience.org/api/trials/v1/NCT06754579/registered